Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Sanaria Inc.

Clinical trials sponsored by Sanaria Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New malaria vaccine trial aims to block infection without causing illness Results expected Sep 2026 (estimated)
  • New malaria vaccine shows promise in african trial Results expected Feb 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 3 Not yet recruiting 1 Completed 2
Sort by
  • Can a single shot of a genetically weakened malaria parasite train the body to fight off the real thing?

    Vaccine Not yet recruiting

    This trial tests a new malaria vaccine, PfSPZ-LARC2, made from live but genetically weakened malaria parasites that stop developing in the liver and never reach the bloodstream. The goal is to see if a single dose can safely and effectively protect healthy adults in Burkina Faso …

    Phase 1 • Sponsor: Sanaria Inc. • Aim: Vaccine

    Last updated Aug 02, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space